cilofungin and anticapsin

cilofungin has been researched along with anticapsin* in 1 studies

Other Studies

1 other study(ies) available for cilofungin and anticapsin

Article	Year
Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:6 Cilofungin (LY121019) was shown to have potent fungicidal activity against clinical isolates of Candida albicans and Candida tropicalis but not Candida parapsilosis. Fungicidal activity was evident against both replicating and non-replicating Candida albicans and was progressive over the first 12 h of incubation. The combination of cilofungin (LY121019) with anticapsin but not with amphotericin B, ketoconazole or 5-fluorocytosine resulted in synergistic fungicidal activity. This compound warrants further investigation of its safety and efficacy in the treatment of Candida infections. Topics: Alanine; Antifungal Agents; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Echinocandins; Humans; Kinetics; Peptides; Peptides, Cyclic	1989

Article

Year

Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:6

Cilofungin (LY121019) was shown to have potent fungicidal activity against clinical isolates of Candida albicans and Candida tropicalis but not Candida parapsilosis. Fungicidal activity was evident against both replicating and non-replicating Candida albicans and was progressive over the first 12 h of incubation. The combination of cilofungin (LY121019) with anticapsin but not with amphotericin B, ketoconazole or 5-fluorocytosine resulted in synergistic fungicidal activity. This compound warrants further investigation of its safety and efficacy in the treatment of Candida infections.

Topics: Alanine; Antifungal Agents; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Echinocandins; Humans; Kinetics; Peptides; Peptides, Cyclic

1989